Market Place
Sourcing Support
Athena Invests €10M in New Indian Pharma Manufacturing Plant
23 Sep 2024 //
PRESS RELEASE
Athena announces the Approval of its DDS facility
23 Sep 2024 //
PRESS RELEASE
Very successful capital increase for NFL Biosciences with over €3 million raised
31 Jan 2023 //
GLOBENEWSWIRE
NFL Biosciences: 2022 first-half business and earnings
25 Oct 2022 //
GLOBENEWSWIRE
New Mumbai R&D Facility Inaugurated By French Consul General Jean-Marc Séré-Charlet
30 Sep 2022 //
CPHI-ONLINE
NFL BIOSCIENCES: co-development agreement for a drug candidate
02 Feb 2022 //
GLOBENEWSWIRE
The call for help from generic drug manufacturers
12 Oct 2021 //
LEFIGARO
Athena’s Acquisition of Effervescent technology, Dossiers and Products
03 Jun 2020 //
PRESS RELEASE
Pharmaboardroom Interview Alexandre Williams
03 Sep 2019 //
PRESS RELEASE
Athena expands its presence with RUSSIA GMP and Australia’s TGA Clearance
10 May 2019 //
PRESS RELEASE
Athena roll out a BRAZIL strategy
07 May 2019 //
PRESS RELEASE
Secnidazole 2g Taste Masked pellets in Sachets for Bacterial Vaginosis launched
29 Apr 2018 //
PRESS RELEASE
Athena Partner has received Ondansetron ODT approval in UK
29 Jan 2018 //
PRESS RELEASE
Athena obtains EU GMP approval for remaining lines of manufacturing
02 Nov 2017 //
PRESS RELEASE
Athena Licenses Veloxis’ Lipid-Lowering Drug AtorFen for Emerging Markets
23 Dec 2011 //
GENENG NEWS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.